, Tracking Stock Market Picks
Enter Symbol:
Allergan, Inc. (AGN) [hlAlert]

up 434.93 %

Allergan, Inc. (AGN) rated Buy by Canaccord Adams

Posted on: Wednesday,  Sep 30, 2009  8:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy Allergan, Inc. (NYSE: AGN) on 09/30/2009, when the stock price was $57.20. Since
then, Allergan, Inc. has gained 434.93% as of 11/24/2015's recent price of $305.98.
If you would have followed this Canaccord Adams's recommendation on AGN, you would have gained 434.93% of your investment in 2246 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/30/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  13.92 %
1 Month up  22.75 %
3 Months up  24.75 %
1 YTD up  24.75 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy